106
Views
11
CrossRef citations to date
0
Altmetric
Clinical Focus: Metabolic Disorders, Diabetes, and Cardiovascular Disease

Focus on Incretin-Based Therapies: Targeting the Core Defects of Type 2 Diabetes

, MD, MACE
Pages 53-65 | Published online: 13 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Stanley S. Schwartz, Paul S. Jellinger & Mary E. Herman. (2016) Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy’s safety profile. Postgraduate Medicine 128:6, pages 609-619.
Read now
Devesh Sennik, Fahad Ahmed & David Russell-Jones. (2012) Exenatide, a GLP-1 agonist in the treatment of Type 2 diabetes. Expert Review of Endocrinology & Metabolism 7:1, pages 15-26.
Read now

Articles from other publishers (8)

Salinee Jantrapirom, Wutigri Nimlamool, Nipon Chattipakorn, Siriporn Chattipakorn, Piya Temviriyanukul, Woorawee Inthachat, Piyarat Govitrapong & Saranyapin Potikanond. (2020) Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity. International Journal of Molecular Sciences 21:5, pages 1725.
Crossref
Erin St Onge, Shannon Miller, Elizabeth Clements, Lindsay Celauro & Ke’la Barnes. (2017) The role of glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes. Journal of Translational Internal Medicine 5:2, pages 79-89.
Crossref
Ning Shao, Hong Yu Kuang, Ming Hao, Xin Yuan Gao, Wen Jian Lin & Wei Zou. (2014) Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews 30:6, pages 521-529.
Crossref
Thundiparambil Azeez Sonia & Chandra P. Sharma. 2014. Oral Delivery of Insulin. Oral Delivery of Insulin 1 57 .
Ciara M. Mulligan, Roy Harper, Janet Harding, Werner McIlwaine, Ann Petruckevitch & Darren M. McLaughlin. (2013) A Retrospective Audit of Type 2 Diabetes Patients Prescribed Liraglutide in Real-Life Clinical Practice. Diabetes Therapy 4:1, pages 147-151.
Crossref
Michelle E. Kimple, Jennifer B. Moss, Harpreet K. Brar, Taylor C. Rosa, Nathan A. Truchan, Renee L. Pasker, Christopher B. Newgard & Patrick J. Casey. (2012) Deletion of Gα Z Protein Protects against Diet-induced Glucose Intolerance via Expansion of β-Cell Mass . Journal of Biological Chemistry 287:24, pages 20344-20355.
Crossref
Ajay Varanasi, Pavan Patel, Antoine Makdissi, Sandeep Dhindsa, Ajay Chaudhuri & Paresh Dandona. (2012) Clinical Use of Liraglutide in Type 2 Diabetes and its Effects on Cardiovascular Risk Factors. Endocrine Practice 18:2, pages 140-145.
Crossref
Mark Evans. 2012. Clinical Pharmacology. Clinical Pharmacology 572 586 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.